Johnson & Johnson expanding neurovascular R&D activities in Galway

Johnson & Johnson expanding neurovascular R&D activities in Galway

The expansion will enable Johnson & Johnson to target specific medical concerns, grow its teams and develop new treatments. Read more: Johnson & Johnson expanding neurovascular R&D activities in Galway

Johnson & Johnson expands R&D activities in Galway | Manufacturing & Supply Chain

Johnson & Johnson MedTech, a leader in neurovascular care, has announced the expansion of its Research, Development and Innovation (RD&I) activities in Galway. The Galway site is a hub for the company’s NTI and RD&I efforts. NTI is focused on understanding unmet needs in neurovascular disease and driving innovation in stroke treatment at the company’s Galway-based centre of excellence. Following a previous expansion announced in 2022, this lates…

Johnson & Johnson expanding neurovascular research and stroke care in Galway - Connacht Tribune - Galway City Tribune

This article first appeared on Galway Bay FM Johnson & Johnson is expanding its neurovascular R&D Activities in Galway, a move which will advance the treatment of stroke. This latest endeavour will enable the MedTech company to expand stroke-specific and liquid embolic procedural R&D capabilities at its Ballybrit base. Minister for Enterprise, Tourism and Employment Peter Burke says this development will further our capabilities in neurovascular…

Johnson & Johnson expanding neurovascular R&D activities in Galway

The expansion will enable Johnson & Johnson to target specific medical concerns, grow its teams and develop new treatments. Read more: Johnson & Johnson expanding neurovascular R&D activities in Galway

What to do in Galway this Weekend

Open the article to view the coverage from This is Galway